Journal
BIOORGANIC & MEDICINAL CHEMISTRY
Volume 54, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2021.116580
Keywords
Staphylococcus aureus; Fluoroquinolone resistance; NorA efflux pump; Dihydroquinazoline; Efflux pump inhibitor; qRT-PCR; Intracellular killing
Funding
- DST-SERB
- DST-INSPIRE fellowships [IF-160438, IF-170007]
- CSIR-JRF
- Council of Scientific and Industrial Research, New Delhi, India [OLP-2035]
- Department of Science and Technology-SERB, New Delhi, India [GPP-0329]
Ask authors/readers for more resources
The study synthesized 17 dihydroquinazoline analogues and found that they significantly reduced drug resistance in S. aureus 1199B as NorA efflux pump inhibitors, with low toxicity in human cells, indicating potential as a therapeutic approach.
Staphylococcus aureus is an emerging human pathogen that has become difficult to treat due to its high resistance against wide range of drugs. Emergence of drug resistant isolates has further convoluted the treatment process. Among different resistance mechanisms, efflux pump proteins play a central role and has made itself a direct approach for therapeutic exploration. To demarcate the role of dihydroquinazoline analogues as NorA efflux pump inhibitor in S. aureus1199B (NorA over producing) strain total seventeen analogues were synthesized and tested for their modulatory effects on norfloxacin and Etbr resistance. Further accumulation assays, bacterial time kill kinetics, cytotoxicity assay were also carried out. The intracellular killing ability of analogues, as EPI was determined using THP-1 monocytes. The binding interaction of analogues with NorA was also predicted. Dihydroquinazoline analogues notably reduced the MIC of norfloxacin and Etbr in S. aureus1199B. In addition to their very low toxicity, they showed high Etbr and norfloxacin accumulation respectively. Further effective over time log reduction in bacterial kill kinetics in presence of these analogues confirmed their role as NorA efflux pump inhibitor. FESEM analysis clearly depicted their effect on the cell surface morphology owing to its lyses. The most significant finding of this study was the ability of analogues to significantly reduce the intracellular S. aureus1199B in human THP-1 monocytes in presence of norfloxacin. Our study has shown for the first time the possibility of developing the dihydroquinazoline analogues as NorA efflux pump inhibitors for S. aureus and control its infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available